Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 26 16
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 31 11
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 64 0
S2N12 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021 2 0
S2N28 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021 2 0
S2X324 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021 2 0